Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,530 | 89,884 | 243,801 | 119,296 | 196,154 |
| Marketable Securities | 275,343 | 308,524 | 117,338 | 24,890 | 190,088 |
| Receivables | 73,689 | 63,569 | 56,176 | 42,690 | 11,805 |
| Inventories | 37,217 | 34,363 | 35,939 | 40,610 | 19,580 |
| Income taxes - deferred | 53,164 | 53,135 | 54,896 | 32,094 | N/A |
| Other current assets | 30,755 | 0 | 0 | 0 | 0 |
| TOTAL | $655,423 | $555,479 | $519,531 | $274,036 | $426,984 |
| Non-Current Assets | |||||
| PPE Net | 30,357 | 1,917 | 1,439 | 1,519 | 1,582 |
| Intangibles | 1,848,947 | 1,067,434 | 1,082,250 | 1,093,732 | 16,597 |
| Other Non-Current Assets | 19,686 | 14,453 | 17,222 | 19,646 | 6,229 |
| TOTAL | $1,898,990 | $1,083,804 | $1,100,911 | $1,114,897 | $24,408 |
| Total Assets | $2,554,413 | $1,639,283 | $1,620,442 | $1,388,933 | $451,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,500 | 132,680 | 38,250 | 34,000 | N/A |
| Accounts payable and accrued liabilities | 39,920 | 6,147 | 5,958 | 7,301 | 1,899 |
| Accrued Expenses | 102,656 | 89,617 | 88,811 | 80,093 | 27,521 |
| Other current liabilities | 96,756 | 95,526 | N/A | 718 | N/A |
| TOTAL | $266,844 | $323,970 | $166,582 | $166,488 | $38,839 |
| Non-Current Liabilities | |||||
| Long Term Debt | 815,067 | 179,706 | 281,904 | 293,905 | N/A |
| Deferred Revenues | 10,012 | 0 | 33,563 | 44,376 | 9,419 |
| Other Non-Current Liabilities | 303,037 | 300,323 | 394,750 | 390,968 | 178,890 |
| TOTAL | $1,367,608 | $602,332 | $782,684 | $762,492 | $215,572 |
| Total Liabilities | $1,634,452 | $926,302 | $949,266 | $928,980 | $254,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,704 | 30,926 | 30,533 | 25,616 | 22,095 |
| Common Shares | 347 | 309 | 305 | 256 | 220 |
| Retained earnings | -304,865 | -284,281 | -317,539 | -330,443 | -473,451 |
| Other shareholders' equity | -3,720 | -3,948 | -3,549 | -3,617 | -3,555 |
| TOTAL | $919,961 | $712,981 | $671,176 | $459,953 | $196,981 |
| Total Liabilities And Equity | $2,554,413 | $1,639,283 | $1,620,442 | $1,388,933 | $451,392 |